- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01182987
SCAN Memory Program Evaluation Study (SMPES)
The SCAN Memory Program Evaluation study is an evaluation of a randomized controlled trial intervention consisting of a care management program for cognitively-impaired health plan members and for their informal/family caregivers. The program includes collaboration between the health plan, partnering medical groups, and community organizations.
Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution. ACCESS, the prototype for the SCAN Memory Program, was developed and tested in San Diego County and was very successful in helping affected patients and their caregivers.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Calabasas, California, United States
- Recruiting
- Davis Research
-
Contact:
- Jason Kerns
- Phone Number: 818-223-4046
- Email: jkerns@davisresearch.com
-
Contact:
- Nicole Cullen
- Email: ncullen@davisresearch.com
-
Sub-Investigator:
- Jason Kerns
-
Los Angeles, California, United States, 90073
- Recruiting
- VA Greater Los Angeles Healthcare System
-
Contact:
- Joshua Chodosh, MD, MSHS
- Phone Number: 310-268-3361
- Email: jchodosh@mednet.ucla.edu
-
Contact:
- Karen Connor, RN, MBA, PhD
- Phone Number: 310-268-3975
- Email: kiconnor@ucla.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Health plan member eligibility includes having a visit-based ICD-9 diagnostic code for dementia or a dementia-specific medication (including donepezil, rivastigmine, galantamine, and memantine) within administrative data any time prior to data inquiry for potential subjects. The health plan member must have a caregiver who can communicate by telephone and though that person might also be a health plan member, health plan membership for caregivers is not required. All subjects must be living in the community and if in a nursing facility, this must be for rehabilitation or respite care but not for long term care. Caregivers must be able to communicate in English or Spanish.
Exclusion Criteria: Person with dementia whose potential participation is declined by their physician. Those who do not have a family or informal caregiver cannot participate and caregivers who do no have telephone access or the capacity to consent to research evaluation are excluded. Patients who reside in nursing facilities as permanent residents are not eligible.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dementia care management
Patients and family caregivers will be offered dementia care management, which includes detailed comprehensive assessment, education, counseling, referrals to community agencies, collaboration with medical providers and frequent telephone follow-up
|
The SCAN Memory Program is a care management program for cognitively-impaired SCAN members and for their informal/family caregivers. The program includes collaboration between SCAN Health Plan, partnering medical groups, and community organizations. Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution. |
No Intervention: Usual care
Patients and care family care givers will receive usual support and medical care offered by the health plan.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Guideline Adherence
Time Frame: 18 months of longer
|
Quality of care process measures will be examined that reflect practice guideline quality indicators measuring patient and caregiver assessment, treatment, education and support, and safety.
Measures are collected at 9 and 18 months using caregiver surveys and medical record abstraction.
|
18 months of longer
|
Program feasibility and fidelity
Time Frame: 6 to 18 months
|
Formative Evaluation consisting of a series of stakeholder semi-structured interviews and data abstraction to monitor the activities of healthplan care managers will be collected at pre-specificed intervals and results will be provivided periodically to the healthplan for ongoing improvements in program delivery.
|
6 to 18 months
|
Healthcare utilization
Time Frame: 18 months
|
Caregiver specific utilization including use of services that care managers may recommend to them and the dementia patient.
Emergency department, hospitalization and ambulatory visits data will also be collected through administrative data and caregiver surveys.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavioral disturbance
Time Frame: 9 months and 18 months
|
Neuropsychiatric inventory questionnaire (NPI-Q)as a caregiver derived assessment on caregiver surveys conducted at baseline, 9 and 18 months.
|
9 months and 18 months
|
Functional Status
Time Frame: 9 and 18 months
|
Using an informant (caregiver)-based measure of 10 complex higher order activities using the Functional Activities Questionnaire (FAQ).
This is a reliable measure of functional status in patients with dementia.
|
9 and 18 months
|
Quality of life
Time Frame: 9 and 18 months
|
Patient health related quality of life (HRQOL) using the Health Utilities Index
|
9 and 18 months
|
Quality of Care
Time Frame: 9 and 18 months
|
Using caregiver surveys, this will be measured with a 5-item scale from the Consumer Assessment of Health Plans Survey 2.0.
|
9 and 18 months
|
Caregiver self-efficacy
Time Frame: 9 months and 18 months
|
caregiver confidence using a 6-item measure that was utilized in prior care management clinical trials
|
9 months and 18 months
|
Caregiver unmet need for assistance
Time Frame: 9 months and 18 months
|
a 2-item, 3-point scale for each covering general caregiveing - bathing, dressing, and transportation
|
9 months and 18 months
|
Caregiver social support
Time Frame: 9 months and 18 months
|
This will be measured in caregiver surveys using a 5-item measure derived from the Medical Outcomes study Social Support Survey (MSSS).
|
9 months and 18 months
|
Caregiver burden
Time Frame: 9 months and 18 months
|
The 22-item Burden Interview is a widely used validated measure to assess stressors experienced by caregivers of persons with dementia.
Each itme uses a 5-point scale (response set).
|
9 months and 18 months
|
Caregiver depression
Time Frame: 9 months and 18 months
|
The Patient Health Questionnaire - Nine (PHQ-9) will be included in caregiver surveys at baseline, 9 and 18 months as a measure of depressive symptoms over the preceding 2 weeks.
|
9 months and 18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joshua Chodosh, MD, MSHS, VA / UCLA
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRC 09-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Dementia Care Management
-
German Center for Neurodegenerative Diseases (DZNE)University of Siegen; Gesundheitsregion Siegerland eG (GRS); Alzheimer Gesellschaft... and other collaboratorsRecruitingDementia | Mild Cognitive Impairment | Dementia Alzheimers | Care ManagementGermany
-
RANDNational Institute on Aging (NIA); Alzheimer's Association; Olive View-UCLA Education...CompletedDementiaUnited States
-
German Center for Neurodegenerative Diseases (DZNE)University Medicine Greifswald; Techniker Krankenkasse; Federal Joint Committee; AOK Nordost and other collaboratorsActive, not recruitingDementia | Nurse's Role | Nurse Physician RelationsGermany
-
German Center for Neurodegenerative Diseases (DZNE)German Federal Ministry of Education and Research; University Medicine Greifswald and other collaboratorsCompletedNeurodegenerative Diseases | Cognitive Impairment | DementiaGermany
-
German Center for Neurodegenerative Diseases (DZNE)University Medicine GreifswaldActive, not recruiting
-
Corporal Michael J. Crescenz VA Medical CenterCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
University of California, Los AngelesPatient-Centered Outcomes Research Institute; Yale University; University of... and other collaboratorsCompleted
-
Chang Gung Memorial HospitalChang Gung University of Science and TechnologyCompleted
-
Chang Gung Memorial HospitalChang Gung University of Science and Technology; National Science and Technology...Not yet recruiting